Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sirius XM Holdings Inc (SIRI) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Sirius XM Holdings IncTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Sirius XM Holdings Inc vs DENTSPLY SIRONA Inc — how do they compare? Sirius XM Holdings Inc trades at $26.63 (market cap $8.87B), while DENTSPLY SIRONA Inc trades at $8.81 (market cap $1.73B). The key difference: Sirius XM Holdings Inc is far larger — about 5.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Sirius XM Holdings Inc for 102 Days and DENTSPLY SIRONA Inc for 72 Days on average.

SIRIXRAY
Market Cap
$8.87B$1.73B
Volume
4,324,6726,198,582
Sector
MediaHealth
52-Week High
$32.59$14.68
52-Week Low
$19.92$8.52
Typical Hold Time
102 Days72 Days
Enterprise Value
$18.16B$3.80B
Dividend Yield
4.1%5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sirius XM Holdings Inc

Sirius XM (SIRI) trades at $26.67, up 2.77% today, with mixed technical signals showing neutral momentum. The stock shows attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, while recent earnings have been inconsistent with two misses and one beat in the last three quarters. The company maintains solid profitability with 47.36% gross margins and positive cash flow generation, supported by recent strategic initiatives including YouTube partnerships and advertising expansion.

The investment case balances value appeal against execution risks. Analyst consensus remains bullish with a $34.43 price target (29% upside), though investors face risks from competitive pressures and inconsistent earnings performance. The company's strong cash flow and strategic partnerships provide growth catalysts, but requires monitoring of subscription trends and advertising revenue execution.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SIRI
93% Buy7% Sell
Avg holding period · 102 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Sirius XM Holdings Inc

SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.

Read more on SIRI →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →